All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Equity

Aker BioMarine rallies on rights deal to buy omega-3 firm

Aker BioMarine, the Norwegian fish food firm, announced plans for its second rights issue since May on Friday, a Nkr250m ($40.5m) deal to finance a joint-venture acquisition.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree